Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunctionJames R. Tribble, Pete A. Williams, Emma Lardner et al.|Redox Biology|2021Cited by 227
Neuroprotection in Glaucoma: NAD+/NADH Redox State as a Potential Biomarker and Therapeutic TargetBledi Petriti, David F. Garway‐Heath, Pete A. Williams et al.|Cells|2021Cited by 50
Widespread retina and optic nerve neuroinflammation in enucleated eyes from glaucoma patientsCarola Rutigliani, Pete A. Williams, James R. Tribble et al.|Acta Neuropathologica Communications|2022Cited by 50
NMNAT2 is a druggable target to drive neuronal NAD productionJames R. Tribble, Pete A. Williams, Melissa Jöe et al.|Nature Communications|2024Cited by 36
Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunctionJames R. Tribble, Pete A. Williams, Amin Otmani et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 14